Photos from Envato
The high burden of heart valve disease is driving its expansion.
GlobalData said the transcatheter aortic valve replacement volume (TAVR) market in India is expected to grow at a compound annual growth rate of about 24% until 2033, due to the high burden of heart valve disease.
Diseases such as rheumatic heart disease and degenerative aortic stenosis are driving the expansion of the sector, further exacerbating socioeconomic challenges and limited health care opportunities.
Despite the growing demand, India accounts for only 3% of the Asia-Pacific market in 2024.
“The challenges remain in achieving consistent, accurate valve placement, especially in patients with complex anatomical structures, which can lead to lateral leakage,” said GlobalData medical device analyst Shreya Jain.
Jain added: “The increased affordability and accessibility, coupled with increasing awareness and ongoing research, will be key to the expansion of the TAVR market in India.”
Join the Healthcare Asia Magazine Community
Since you're here…
…You can promote your company with us and connect with your customers in a variety of ways. Our team can help you Dight and create advertising campaigns on print and digitally on this website and on print magazines.
We can also organize real-life or digital events for you and find thought leader speakers and industry leaders who can become your potential partners to attend. We also run a number of award programs that give you the opportunity to earn your achievements this year and you can join as a participant or sponsor.
Let us help you move your business forward with a good partnership!
